Genoptix Reports Strong Financial Results for the Fourth Quarter and Full... (ome 817 5...)

Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007

Date:2/12/2008

ome 817 53 1,062 246

Interest expense (122) (96) (353) (384)

Other income - (11) 41 308

Income (loss) before income taxes 4,839 (358) 13,792 (3,759)

Provision for income taxes (165) - (439) -

Net income (loss) $4,674 $(358) $13,353 $(3,759)

Net income (loss) per share(1)(2):

Basic $0.30 $(2.40) $1.20 $(33.74)

Diluted $0.27 $(2.40) $0.78 $(33.74)

Shares used to compute net income

(loss) per share:

Basic 10,367 149 2,756 111

Diluted 11,909 149 4,246 111

(1) As a result of the conversion of the Company's preferred stock into

11,032 shares of common stock upon completion of the Company's IPO in

November 2007, there is a lack of comparability in the basic and

diluted net income (loss) per share amounts for the periods presented

above. See Note 1 to the Notes to Consolidated Financial Statements in

the Annual Report on Form 10-K for the year ended December 31, 2007

for calculations of the pro forma net income (loss) per share for the

periods presented.

(2) For the three months ended December 31, 2007, $1,514 of the Company's

net income of $4,674 was allocated to preferred stockholders for

purposes of calculating net income per share pursuant to the terms of

the preferred stock, resulting in $3,160 of net income allocable to

common stockholders. For the year ended December 31, 2007, $10,036 of

the Company's net income of $13,353 was allocated to preferred

stockholders for purposes of calculating net inc
'/>"/>

Post Your Comments:

Genoptix Reports Strong Financial Results for the Fourth Quarter and Full...(ome 817 5...),Health